葡萄糖依赖性促胰岛素多肽独立于胰岛素和血糖抑制骨吸收
本研究在10例C肽阴性的1型糖尿病男性患者中开展随机双盲交叉试验,比较静脉输注GIP、GLP-1或安慰剂在低血糖和高血糖条件下对骨转换标志物的影响。结果显示GIP在低血糖和高血糖条件下均显著抑制CTX,且不依赖于内源性胰岛素分泌,但对P1NP无影响,对PTH的抑制在90分钟后消失。
要点
- GIP在低血糖条件下将CTX从基线抑制达59±18%,而生理盐水为24±10%(P<0.0001)。
- GIP在高血糖条件下将CTX从基线抑制达59±19%,而生理盐水为7±9%(P<0.0001)。
- GIP对P1NP无影响,对PTH的抑制在60分钟时显著但90分钟后消失。
核心结论
- 短期GIP输注可显著减少骨吸收,且不依赖于内源性胰岛素分泌,在血糖升高和血糖偏低时均成立,但对P1NP无影响,对PTH的抑制在90分钟后消失。
研究设计与样本
- 随机、双盲、交叉研究,共5个研究日,纳入10例C肽阴性的1型糖尿病男性患者。
主要发现
- 低血糖条件下,GIP使CTX从基线抑制达59±18%,生理盐水为24±10%(P<0.0001)。
- 高血糖条件下,GIP使CTX从基线抑制达59±19%,生理盐水为7±9%(P<0.0001)。
- 低血糖和高血糖条件下,P1NP绝对值在各研究日之间无差异。
- 高血糖条件下,GIP在60分钟时抑制PTH较生理盐水显著(P<0.01),但90分钟后该差异消失。
关键数值与推荐
- 低血糖条件:血浆葡萄糖维持在3至7 mmol/L区间120分钟;静脉输注GIP 4 pmol×kg-1×min-1、GLP-1 1 pmol×kg-1×min-1或生理盐水。
- 高血糖条件:血浆葡萄糖维持在12 mmol/L 90分钟;静脉输注GIP或生理盐水。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The gut hormone glucose-dependent insulinotropic polypeptide (GIP) causes postprandial insulin release and inhibits bone resorption assessed by carboxy-terminal collagen crosslinks (CTX). OBJECTIVE: To study if GIP affects bone homeostasis biomarkers independently of insulin release and glycemic level. DESIGN: Randomized, double-blinded, crossover study with 5 study days. PATIENTS: Ten male C-peptide-negative patients with type 1 diabetes. INTERVENTIONS: On 3 matched days with "low glycemia" (plasma glucose in the interval 3 to 7 mmol/L for 120 minutes), we administered intravenous (IV) GIP (4 pmol × kg-1 × min-1), glucagon-like peptide 1 (1 pmol × kg-1 × min-1), or placebo (saline), and on 2 matched days with "high glycemia" (plasma glucose 12 mmol/L for 90 minutes), we administered either GIP or saline. MAIN OUTCOME MEASURES: CTX, procollagen type 1 N-terminal propeptide (P1NP), and parathyroid hormone (PTH). RESULTS: During low glycemia: GIP progressively suppressed CTX from baseline by up to 59 ± 18% compared with 24 ± 10% during saline infusion (P < 0.0001). Absolute values of P1NP and PTH did not differ between days. During high glycemia: GIP suppressed CTX from baseline by up to 59 ± 19% compared with 7 ± 9% during saline infusion (P < 0.0001). P1NP did not differ between days. GIP suppressed PTH after 60 minutes compared with saline (P < 0.01), but this difference disappeared after 90 minutes. CONCLUSIONS: Short-term GIP infusions robustly reduce bone resorption independently of endogenous insulin secretion and during both elevated and low plasma glucose, but have no effect on P1NP or PTH after 90 minutes.
引用
- Christensen MB, Lund A, Calanna S, et al. Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia. J Clin Endocrinol Metab. 2018. PMID: 29099978. doi:10.1210/jc.2017-01949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。